Rep. Brett Guthrie @RepGuthrie
Passed the House: FDA Act of 2022 that I'm co-leading would lower costs, secure medical supply chains, and protect access to cures. It also allows FDA to provide timely reviews of drug and device applications and save taxpayer money by collecting application fees from industry. https://t.co/Fc4ZagxilW — PolitiTweet.org